Monte Rosa Therapeutics, Inc. (GLUE)
16.99
-0.86
(-4.82%)
USD |
NASDAQ |
Dec 09, 16:00
16.99
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Market Cap: 1.106B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 251.38B |
| AVITA Medical, Inc. | 107.64M |
| NanoVibronix, Inc. | 5.158M |
| Mirum Pharmaceuticals, Inc. | 3.361B |
| Day One Biopharmaceuticals, Inc. | 847.07M |
Market Cap Related Metrics
| PE Ratio | 55.63 |
| PS Ratio | 7.231 |
| Price to Book Value | 4.500 |
| Price to Free Cash Flow | 9.052 |
| Price | 16.99 |
| Earnings Yield | 1.80% |
| Operating PE Ratio | 154.23 |
| Normalized PE Ratio | 55.63 |